1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Yixintang Pharmaceutical Group Co., Ltd.
  6. Summary
    002727   CNE100001WJ8

YIXINTANG PHARMACEUTICAL GROUP CO., LTD.

(002727)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-08-10
25.55 CNY   +1.79%
06/22Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online
MT
04/29Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/22Yixintang Pharmaceutical Group Co., Ltd. Proposes Cash Dividend on A Shares for the Year 2021, Payable on April 29, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
25.17 24.71 25.1 25.55 25.32 Last
6259283 5931133 5300468 4361097 3151138 Volume
-2.21% -1.83% +1.58% +1.79% -0.90% Change
Estimated financial data (e)
Sales 2022 16 839 M 2 497 M 2 497 M
Net income 2022 1 045 M 155 M 155 M
Net cash position 2022 1 581 M 234 M 234 M
P/E ratio 2022 14,2x
Yield 2022 1,55%
Sales 2023 20 100 M 2 980 M 2 980 M
Net income 2023 1 279 M 190 M 190 M
Net cash position 2023 1 873 M 278 M 278 M
P/E ratio 2023 11,7x
Yield 2023 1,91%
Capitalization 15 093 M 2 238 M 2 238 M
EV / Sales 2022 0,80x
EV / Sales 2023 0,66x
Nbr of Employees 32 503
Free-Float 48,9%
More Financials
Company
Yixintang Pharmaceutical Group Co., Ltd., formerly Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd., is a China-based company principally engaged in the pharmaceutical chain retailing and pharmaceutical wholesaling businesses. The Company’s main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The Company... 
Sector
Drug Retailers
Calendar
08/30Earnings Release
More about the company
Ratings of Yixintang Pharmaceutical Group Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
06/22Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online
MT
04/29Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter..
CI
04/22Yixintang Pharmaceutical Group Co., Ltd. Proposes Cash Dividend on A Shares for the Yea..
CI
04/21Yixintang Pharmaceutical Group Co., Ltd. Approves Profit Distribution
CI
04/01UBS Adjusts Yixintang Pharmaceutical's Price Target to 51 Yuan From 56.50 Yuan, Keeps a..
MT
03/30Yixintang Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2021
CI
03/14Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year End..
CI
2021Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months E..
CI
2021Yixintang Pharmaceutical Co., Ltd. announced that it has received CNY 250 million in fu..
CI
2021Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year End..
CI
2021Yixintang Pharmaceutical Co., Ltd. announced that it expects to receive CNY 250 million..
CI
2021YIXINTANG PHARMACEUTICAL : Pharma to List Over 2 Million Newly Unlocked Restricted Shares
MT
2021Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter..
CI
2021Yixintang Pharmaceutical Group Co., Ltd. Approves Cash Dividend A Shares for the Year 2..
CI
2021YIXINTANG PHARMACEUTICAL : Pharma to List New Shares Issued Under Incentive Plan
MT
More news
News in other languages on YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
06/22Pékin envisage d'interdire aux entreprises de soins de santé sur Internet de vendre des..
04/29Yixintang Pharmaceutical Group Co., Ltd. annonce ses résultats pour le premier trimestr..
04/22Yixintang Pharmaceutical Group Co., Ltd. Propose un dividende en espèces sur les action..
04/21Yixintang Pharmaceutical Group Co., Ltd. approuve la distribution des bénéfices
03/30Yixintang Pharmaceutical Group Co., Ltd. Propose un dividende final en espèces pour l'a..
More news
Analyst Recommendations on YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
More recommendations
Chart YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
Duration : Period :
Yixintang Pharmaceutical Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 25,32 CNY
Average target price 36,84 CNY
Spread / Average Target 45,5%
EPS Revisions
Managers and Directors
Hong Xian Ruan Chairman & President
Si Shun Dai Chief Financial Officer
Ping Feng Chairman-Supervisory Board
Xian Ming Yang Independent Director
Xiao Hai Long Independent Director